Health & Fitness
Health and Fitness
Health and Fitness
Fri, February 13, 2009
Thu, February 12, 2009 Clinical Data, Inc. To Present at the Roth 21st Annual OC Growth Stock Conference
NEWTON, Mass.--([ BUSINESS WIRE ])--Clinical Data, Inc. (NASDAQ: CLDA), today announced that Drew Fromkin, President and Chief Executive Officer, will be presenting a corporate overview at the ROTH 21st Annual OC Growth Stock Conference on Tuesday, February 17, 2009 at The Ritz-Carlton, Laguna Niguel in Dana Point, CA. Clinical Data's presentation will take place at 3:30 p.m. PT. A live audio and archived webcast of the Company presentation can be accessed through the Company's website at [ www.clda.com ].
About Clinical Data, Inc.
Clinical Data is a global biotechnology company unlocking the potential of molecular discovery, From Targeted Science to Better Healthcare®. The Company's PGxHealth® division is utilizing its proprietary portfolio of biomarkers to develop and commercialize a broad range of targeted therapeutics as well as pharmacogenetic tests that help predict drug safety and efficacy, thereby reducing health care costs. Its Cogenics® division provides genomics services to both research and regulated environments.Through these divisions, Clinical Data is leveraging advances in molecular discovery to provide tangible benefits for patients, doctors, scientists and health plans worldwide. To learn more, please visit the Company's website at [ www.clda.com ].
